Ad Dollars Follow Eyeballs to Web: Guesstimating Total Pharma Web Ad Spending

Guesstimating Total Pharma Web Ad Spending. Internet advertising revenue in the United States totaled $26.0 billion for the full year of 2010. How much of this was spent by pharma? Best guesstimate: $1 billion, which accounts for about 11% of the total pharma physician and consumer ad spend.

Physicians Favor Brands With a Compelling Adherence Program

This article summarizes the results of a survey of physicians designed to assess the value of various adherence solutions -- including HealthPrize -- and the potential of these solutions to influence physicians' prescribing behavior.

Certain Physician-Drug Industry Relationships Have Declined Dramatically

The authors of a physician survey published in the November 8, 2010, issue of Archives of Internal Medicine conclude 'given that 83.8% of physicians have PIRs, it is clear that industry still has substantial financial links with the nation's physicians. These findings support the ongoing need for a national system of disclosure of PIRs [Physician-Drug Industry Relationships].' Such a system is part of the Physician Sunshine Law, which is scheduled to go into effect in 2012 with public disclosure of payments scheduled to begin September, 2013.

Pharma Marketing News Vol. 10, No. 18: 1 December 2011

Welcome to Volume 10, Issue #18 (1 DECEMBER 2011) of Pharma Marketing News.

New Big Pharma Economies of Scale

How many patients are needed these days to make a drug a billion dollar blockbuster? Less than you think. What are the implications for pharmaceutical marketing?

Pharma Spending on Internet, DTC, and Docs

How much money the pharmaceutical industry spends on Internet marketing, direct-to-consumer advertising, and physician detailing are always topics of interest and 2010 was no exception. 2010 was, however, a turning point in bringing more attention to payments made to physicians for speaking, consulting, and research.

Checking Under the Hood of Pharma Mobile Apps

Let's look 'under the hoods' of two pharma-sponsored mobile apps and compare disclaimers. We'll compare Janssen's PASI calculator, which has an update disclaimer, with the new AFib Educator 2.0 app developed by Sanofi-Aventis.

Consequences of eDetailing Technology

The Death of the Traditional Pharma Salesman and the Birth of the 'Sales Cyborg.' eDetailing in one form or another seems to be making a comeback since the recession hit the drug industry in 2007 and 2008. Which is the 'chicken' and which is the 'egg'? Did the uptick in adoption of eDetailing technology lead to the recent layoff of pharma reps or were reps laid off because of the economy and subsequently replaced by machines?

The Big C in the Big Apple

HepC.tv is featuring the video 'Man-on-the-Street: New Yorkers' Reactions to the Big Yellow C.' Is it effective? How do we know?

Pfizer Battles to Protect Lipitor Cash Cow

Lipitor Won't Go Gentle Into that Good Generic Night. Pfizer is taking a number of steps to protect it's Lipitor franchise and it hopes that many patients currently taking Lipitor will remain loyal to the brand.

STAY CONNECTED

29,540FollowersFollow
- Advertisement -